MedPath

Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC

Not Applicable
Completed
Conditions
Hepatocellular Carcinoma
Interventions
Radiation: Conventional CT (radiation)
Radiation: Low radiation dose CT
Drug: Conventional CT (contrast agent)
Drug: Low contrast dose CT
Other: Deep-learning based contrast boosting algorithms
Registration Number
NCT04722120
Lead Sponsor
Seoul National University Hospital
Brief Summary

The purpose of this study is to investigate the image quality and clinical feasibility of double low-dose liver computed tomography using a deep-learning-based iodine contrast boosting algorithm in participants at high risk for hepatocellular carcinoma.

Detailed Description

The purpose of this study is to investigate the image quality (CNR, subjective inage quality, vessel and lesion conspicuity) and clinical feasibility (rate of lesion detection) of double low-dose liver computed tomography using a deep-learning-based iodine contrast boosting algorithm in participants at high risk for hepatocellular carcinoma.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria
  • Liver cirrhosis
  • Tumor marker (aFP, PIVKA) elevation
  • Nodular lesion on USG
  • Received RFA for HCC
Exclusion Criteria
  • hypersensitivity at iodine
  • GFR under 30
  • BMI over 30
  • Nursing or pregnant women
  • enrolled the other study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Conventional liver CTConventional CT (radiation)Underwent conventional liver CT on HCC high-risk patient
Conventional liver CTConventional CT (contrast agent)Underwent conventional liver CT on HCC high-risk patient
Double low dose CTLow radiation dose CTUnderwent double low dose liver CT with 30% lower radiation dose and 20% contrast media on HCC high-risk patient
Double low dose CTLow contrast dose CTUnderwent double low dose liver CT with 30% lower radiation dose and 20% contrast media on HCC high-risk patient
Double low dose CTDeep-learning based contrast boosting algorithmsUnderwent double low dose liver CT with 30% lower radiation dose and 20% contrast media on HCC high-risk patient
Primary Outcome Measures
NameTimeMethod
Detection rate of solid focal lesion in liver12 months after last patient's image work up

diagnostic performance

Quantitative image quality analysisImmediate after study enrollement

Contrast-to-Noise

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath